Latest / Mesa News Today | 2 Min News | The Daily News Now!
Breakthrough Pill for Pancreatic Cancer | Mesa News
FDA just approved a groundbreaking pill for advanced pancreatic cancer—daraxonrasib, now branded Rasonque—targeting a previously “undruggable” protein found in 90% of cases. In trials, patients lived nearly twice as long compared to chemo, with far fewer side effects. Even a former senator’s public praise sparked early access and national buzz. At $39,800 per month, it’s pricey—but offers renewed hope for a disease with few options. Not a cure, but a major leap forward in the fight against one of medicine’s toughest cancers. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.